REPLIMUNE GROUP, INC. Income Taxes Paid
REPLIMUNE GROUP, INC. (REPL) reported Income Taxes Paid of $300.00 thousand for the 9-month period ending 2023-12-31, per its 10-Q filed 2024-02-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-02-08
- REPLIMUNE GROUP, INC. income taxes paid for the quarter ending 2023-12-31 was $0.00.
- REPLIMUNE GROUP, INC. income taxes paid for the quarter ending 2022-12-31 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $300.00K 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-07 | ||
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $0.00 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |